Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT00517296
- Phase
- PHASE4
- Status
- Completed
Conditions
- Crohn Disease
- Rectal Fistula
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- EUA with seton placement if necessary — PROCEDUREPatients randomized to the combination therapy group, the surgeon will have access to EUS findings.
- adalimumab — DRUGPatients began therapy with adalimumab using clinic standards for dosing.
- EUS — PROCEDUREPatients in combination therapy group had an EUS done every 12 weeks to help guide therapy.
Study Details
This study is to assess whether utilizing endoscopic ultrasound(EUS) to guide treatment can improve durable fistula healing in patients with Crohn's perianal fistulas and to get preliminary information regarding the effectiveness of Adalimumab for Crohn's perianal fistulas.
Key Dates
- Start date
- Jan 31, 2008
- Status verified
- Mar 2017
- Primary completion
- Dec 31, 2014
- Completion
- Dec 31, 2015
Study Design
- Enrollment
- 21 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Adalimumab with EUS guided therapyPatients will be randomized to adalimumab treatment with EUS guided therapy decisions. Colorectal surgeon will have access to EUS data prior to EUA with possible seton placement.
- Active Comparator: AdalimumabPatients will be randomized to adalimumab treatment. Colorectal surgeon will not have access to EUS data prior to EUA with possible seton placement.
Primary Outcome Measure
Number of Participants With Durable Fistula Healing [ Time Frame: at week 48 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | - |
Find similar trials in Nashville, TN
By condition
By research site
Related Studies
- Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic RemissionRecruiting · University of California, San Diego · Irvine, California
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruiting · University of California, San Diego · La Jolla, California
- Autologous Stem Cell Transplant for Crohn's DiseasePHASE2 · Recruiting · Aaron Etra · New York, New York
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama